• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类冠状病毒受体综述:带冠状病毒的宿主细胞靶标

A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing Viruses.

机构信息

Biophysics Department, Faculty of Science, Cairo University, Giza 12511, Egypt.

Physics Department, Faculty of Science, Alexandria University, Alexandria 21519, Egypt.

出版信息

Molecules. 2021 Oct 26;26(21):6455. doi: 10.3390/molecules26216455.

DOI:10.3390/molecules26216455
PMID:34770863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8587140/
Abstract

A novel human coronavirus prompted considerable worry at the end of the year 2019. Now, it represents a significant global health and economic burden. The newly emerged coronavirus disease caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the primary reason for the COVID-19 global pandemic. According to recent global figures, COVID-19 has caused approximately 243.3 million illnesses and 4.9 million deaths. Several human cell receptors are involved in the virus identification of the host cells and entering them. Hence, understanding how the virus binds to host-cell receptors is crucial for developing antiviral treatments and vaccines. The current work aimed to determine the multiple host-cell receptors that bind with SARS-CoV-2 and other human coronaviruses for the purpose of cell entry. Extensive research is needed using neutralizing antibodies, natural chemicals, and therapeutic peptides to target those host-cell receptors in extremely susceptible individuals. More research is needed to map SARS-CoV-2 cell entry pathways in order to identify potential viral inhibitors.

摘要

一种新型人类冠状病毒在 2019 年末引起了相当大的关注。如今,它给全球健康和经济带来了巨大的负担。由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的新型冠状病毒疾病是 COVID-19 全球大流行的主要原因。根据最近的全球数据,COVID-19 已导致约 2.433 亿例疾病和 490 万人死亡。几种人类细胞受体参与病毒对宿主细胞的识别和进入。因此,了解病毒如何与宿主细胞受体结合对于开发抗病毒治疗方法和疫苗至关重要。目前的工作旨在确定与 SARS-CoV-2 和其他人类冠状病毒结合以进入细胞的多种宿主细胞受体。需要使用中和抗体、天然化学物质和治疗性肽进行广泛研究,以针对那些极易受感染的个体的宿主细胞受体。需要进一步研究 SARS-CoV-2 细胞进入途径,以确定潜在的病毒抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38d/8587140/dc798f9d02b5/molecules-26-06455-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38d/8587140/17baed1487ea/molecules-26-06455-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38d/8587140/a08ee8b5c5da/molecules-26-06455-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38d/8587140/dc798f9d02b5/molecules-26-06455-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38d/8587140/17baed1487ea/molecules-26-06455-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38d/8587140/a08ee8b5c5da/molecules-26-06455-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38d/8587140/dc798f9d02b5/molecules-26-06455-g003.jpg

相似文献

1
A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing Viruses.人类冠状病毒受体综述:带冠状病毒的宿主细胞靶标
Molecules. 2021 Oct 26;26(21):6455. doi: 10.3390/molecules26216455.
2
SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.SARS-CoV-2 进化适应宿主进入和识别病毒-宿主相互作用中受体 O-乙酰神经氨酸糖基化。
Int J Mol Sci. 2020 Jun 26;21(12):4549. doi: 10.3390/ijms21124549.
3
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
4
Exploring SARS-CoV-2 Spikes Glycoproteins for Designing Potential Antiviral Targets.探索 SARS-CoV-2 刺突糖蛋白以设计潜在的抗病毒靶点。
Viral Immunol. 2021 Oct;34(8):510-521. doi: 10.1089/vim.2021.0023. Epub 2021 May 20.
5
Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)相关的2019冠状病毒病大流行的出现、传播及潜在治疗靶点
Cell Physiol Biochem. 2020 Aug 25;54(4):767-790. doi: 10.33594/000000254.
6
An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.贝塔冠状病毒病毒进入抑制剂的最新综述:从过去的发现中吸取教训,推进 COVID-19 药物发现。
Curr Top Med Chem. 2021;21(7):571-596. doi: 10.2174/1568026621666210119111409.
7
Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.SARS-CoV-2 刺突蛋白中与 ACE2 和中和抗体相互作用的受体结合基序的关键残基。
Cell Mol Immunol. 2020 Jun;17(6):621-630. doi: 10.1038/s41423-020-0458-z. Epub 2020 May 15.
8
SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig.SARS-CoV-2 及三种相关冠状病毒利用多种 ACE2 同源物,可被改良的 ACE2-Ig 有效阻断。
J Virol. 2020 Oct 27;94(22). doi: 10.1128/JVI.01283-20.
9
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.SARS-CoV-2 及其他人类致病冠状病毒的抗病毒药物和可用药靶的现状。
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
10
Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.SARS-CoV-2 刺突蛋白在细胞进入中的动力学:氨基末端结构域中的控制元件。
mBio. 2021 Aug 31;12(4):e0159021. doi: 10.1128/mBio.01590-21. Epub 2021 Aug 3.

引用本文的文献

1
Receptor Binding for the Entry Mechanisms of SARS-CoV-2: Insights from the Original Strain and Emerging Variants.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入机制的受体结合:来自原始毒株和新出现变体的见解
Viruses. 2025 May 10;17(5):691. doi: 10.3390/v17050691.
2
Middle East respiratory syndrome coronavirus (MERS-CoV) internalization does not rely on DPP4 cytoplasmic tail signaling.中东呼吸综合征冠状病毒(MERS-CoV)的内化不依赖于二肽基肽酶4(DPP4)的细胞质尾信号传导。
Npj Viruses. 2024 Dec 30;2(1):67. doi: 10.1038/s44298-024-00080-y.
3
Identification of (L.) Merr as a Novel Potential Therapeutic Agent Against COVID-19 and Pharyngitis.

本文引用的文献

1
GRP78: A possible relationship of COVID-19 and the mucormycosis; in silico perspective.葡萄糖调节蛋白78:2019冠状病毒病与毛霉菌病之间可能的关系;计算机模拟视角
Comput Biol Med. 2021 Dec;139:104956. doi: 10.1016/j.compbiomed.2021.104956. Epub 2021 Oct 23.
2
Chitosan derivatives: A suggestive evaluation for novel inhibitor discovery against wild type and variants of SARS-CoV-2 virus.壳聚糖衍生物:新型 SARS-CoV-2 病毒野生型和变异株抑制剂发现的有价值评估。
Int J Biol Macromol. 2021 Sep 30;187:492-512. doi: 10.1016/j.ijbiomac.2021.07.144. Epub 2021 Jul 27.
3
Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19.
鉴定(L.)Merr为一种针对新型冠状病毒肺炎和咽炎的新型潜在治疗剂。
Molecules. 2025 Feb 25;30(5):1055. doi: 10.3390/molecules30051055.
4
Leveraging Artificial Intelligence and Gene Expression Analysis to Identify Some Potential Bovine Coronavirus (BCoV) Receptors and Host Cell Enzymes Potentially Involved in the Viral Replication and Tissue Tropism.利用人工智能和基因表达分析来鉴定一些潜在的牛冠状病毒(BCoV)受体以及可能参与病毒复制和组织嗜性的宿主细胞酶。
Int J Mol Sci. 2025 Feb 4;26(3):1328. doi: 10.3390/ijms26031328.
5
Cyanobacteria Lectin (MVL) Interacts with SARS-CoV-2 Spike Protein Receptor Binding Domains (RBDs) via Protein-Protein Interaction.蓝藻凝集素 (MVL) 通过蛋白-蛋白相互作用与 SARS-CoV-2 刺突蛋白受体结合域 (RBD) 相互作用。
Int J Mol Sci. 2024 Jun 18;25(12):6696. doi: 10.3390/ijms25126696.
6
Insights into the Activation of Unfolded Protein Response Mechanism during Coronavirus Infection.冠状病毒感染期间未折叠蛋白反应机制激活的见解
Curr Issues Mol Biol. 2024 May 5;46(5):4286-4308. doi: 10.3390/cimb46050261.
7
Recombination analysis on the receptor switching event of MERS-CoV and its close relatives: implications for the emergence of MERS-CoV.MERS-CoV 及其近亲受体转换事件的重组分析:对 MERS-CoV 出现的启示。
Virol J. 2024 Apr 10;21(1):84. doi: 10.1186/s12985-024-02358-2.
8
SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling.SARS-CoV-2 nsp15 内切核酸酶拮抗 dsRNA 诱导的抗病毒信号。
Proc Natl Acad Sci U S A. 2024 Apr 9;121(15):e2320194121. doi: 10.1073/pnas.2320194121. Epub 2024 Apr 3.
9
Causes and Consequences of Coronavirus Spike Protein Variability.冠状病毒刺突蛋白变异性的原因和后果。
Viruses. 2024 Jan 25;16(2):177. doi: 10.3390/v16020177.
10
COVID-19 and the brain: understanding the pathogenesis and consequences of neurological damage.新型冠状病毒肺炎与脑:认识神经系统损伤的发病机制和后果。
Mol Biol Rep. 2024 Feb 22;51(1):318. doi: 10.1007/s11033-024-09279-x.
预先存在的心血管疾病而非心血管危险因素导致 COVID-19 患者的死亡率升高。
BMC Cardiovasc Disord. 2021 Jul 3;21(1):327. doi: 10.1186/s12872-021-02137-9.
4
Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective.通过 GRP78 的识别在 SARS-CoV-2 的英国、南非和巴西变异株中增强;一种计算机模拟的观点。
Biochem Biophys Res Commun. 2021 Jul 12;562:89-93. doi: 10.1016/j.bbrc.2021.05.058. Epub 2021 May 21.
5
A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19.对新型冠状病毒肺炎患者合并症的地理差异以及相关严重程度和死亡率的系统评价与荟萃分析。
Sci Rep. 2021 Apr 20;11(1):8562. doi: 10.1038/s41598-021-88130-w.
6
Corona Viruses: A Review on SARS, MERS and COVID-19.冠状病毒:关于严重急性呼吸综合征、中东呼吸综合征和新型冠状病毒肺炎的综述。
Microbiol Insights. 2021 Mar 19;14:11786361211002481. doi: 10.1177/11786361211002481. eCollection 2021.
7
Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19.与 COVID-19 中 SARS-CoV-2 病毒亚群相关的住院和死亡。
Sci Rep. 2021 Feb 26;11(1):4802. doi: 10.1038/s41598-021-82850-9.
8
Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?SARS-CoV-2 病毒是否可以使用多种受体进入宿主细胞?
Int J Mol Sci. 2021 Jan 20;22(3):992. doi: 10.3390/ijms22030992.
9
Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico.在计算机模拟中,通过GRP78的宿主细胞识别在新冠病毒的英国新变种中得到增强。
J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2021.01.015. Epub 2021 Jan 22.
10
Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design.刺突蛋白在 Sars-CoV-2 疫苗设计中的结构域和功能。
Viruses. 2021 Jan 14;13(1):109. doi: 10.3390/v13010109.